An article titled, New findings on the link between CRISPR gene-editing and mutated cancer cells, discusses how researchers at Karolinska Institutet in Sweden have discovered that during gene editing with the CRISPR technique (Clustered Regularly Interspaced Short Palindromic Repeats). CRISPR is a component of bacterial immune systems that can break DNA and has been repurposed as a tool for gene editing. During this process, they discovered a protein called p53, which protects cells from DNA damage and gets activated. However, cells with mutated p53 have an advantage in surviving this process, which can lead to cancer.

P53 Schematic

This relates to Unit 7, Molecular Genetics, in AP Biology because we learned about how genes mutate. Gene mutation refers to a change in the nucleotide sequence of a gene. The researchers’ discovery shows how genes mutate, specifically the p52, and how that can interact with the CRISPR technique. 

Furthermore, the study shows that by temporarily inhibiting p53 could minimize the buildup of mutated cells while keeping CRISPR’s efficiency intact. With this research, scientist are on the right path to creating more specific cancer treatments in the future.

Additionally, researchers discovered a network of genes associated with p53 mutations, which contribute to cell enrichment. However, temporarily blocking p53 can reduce this enrichment. The study created CRISPR experiments on isolated cells and examined a database. More study is needed to determine the scope of this problem in healthcare settings. Several research organizations funded the study.

The CRISPR technique for gene editing is beneficial to my own life as I have many family members who have battled cancer. It is extremely discouraging to watch, especially since there is no cure; however, with this technique, I am hopeful that the future will bring advancements to cancer treatment and hopefully one day put an end to the disease. SO, who else is excited to see how far in cancer studies the CRISPR technique can take us?

Print Friendly, PDF & Email